Pre-Treatment T-Cell Receptors (TCR) Repertoire in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Single Agent Immunotherapy

被引:0
|
作者
Abed, A. [1 ]
Calapre, L. [2 ]
Bowyer, S. [3 ]
Millward, M. [4 ]
Gray, E. [2 ]
机构
[1] Linear Clin Res, Oncol, Nedlands, WA, Australia
[2] Edith Cowan Univ, Med Sci, Joondalup, WA, Australia
[3] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
[4] Linear Clin Res, Nedlands, WA, Australia
关键词
T-CR repertoire; Non-small cell lung cancer; Immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA12.04
引用
收藏
页码:S870 / S870
页数:1
相关论文
共 50 条
  • [1] Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
    Abed, A.
    Calapre, L.
    Bowyer, S.
    Millward, M.
    Gray, E. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1344 - S1344
  • [2] Prognostic and predictive value of pre-treatment T-Cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
    Abed, Afaf
    Calapre, Leslie
    Bowyer, Samantha
    Millward, Michael
    Gray, Elin
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [3] PROGNOSTIC AND PREDICTIVE VALUE OF PRETREATMENT T-CELL RECEPTORS (TCR) REPERTOIRE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH SINGLE AGENT IMMUNOTHERAPY
    Abed, Afaf
    Gray, Elin
    Millward, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A73 - A73
  • [4] Circulating pre-treatment T-Cell receptor repertoire as a predictive biomarker in non-small cell lung cancer patients treated with pembrolizumab
    Gray, E. S.
    Abed, A.
    Beasley, A.
    Reid, A.
    Law, N. C.
    Leslie, C.
    Millward, M.
    Lo, J.
    ANNALS OF ONCOLOGY, 2023, 34
  • [5] Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated with Immunotherapy
    Goni, A. S.
    Ramirez, A.
    Cruellas, M.
    Esteban, P.
    Galvez, E. M.
    Gascon-Ruiz, M.
    Isla, D.
    Martinez-Lostao, L.
    Ocariz, M.
    Pano, J. R.
    Pardo, J.
    Quilez, E.
    Torres-Ramon, I.
    Yubero, A.
    Zapata, M.
    Lastra, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S570 - S571
  • [6] Peripheral T-Cell Receptor Repertoire Differentiates a Typical Progression in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Han, J.
    Lin, Y.
    Li, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S100 - S101
  • [7] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [8] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [9] T-Cell Receptor Repertoire Profiling as a Predictive Biomarker for Immunotherapy in Unresectable Stage III Non-small Cell Lung (NSCLC)
    Trachu, N.
    Iemwimangsa, N.
    Anantaya, D.
    Lumjiaktase, P.
    Teoh, V. -H.
    Oranratnachai, S.
    Thamrongjirapa, T.
    Khiewngam, K.
    Monnamo, N.
    Sanvarinda, P.
    Incharoen, P.
    Charoenyingwattana, A.
    Chantratita, W.
    Reungwetwattana, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S445 - S445
  • [10] Influence of pre-treatment nutrition and inflammation on immunotherapy response in non-small cell lung cancer
    Robinson, Lary A.
    Kim, Youngchul
    Buro, Acadia
    Hogue, Stephanie R.
    Bailey, Alexis
    DeNicola, Gina M.
    Pierce, Christine
    Umbarger, Mark
    Byrd, Doratha A.
    CANCER RESEARCH, 2024, 84 (06)